Abstract:OBJECTIVE: The expression of S100A6 (calcyclin), a member of the S100 calcium binding protein family, is elevated in a number of malignant tumors, but there have been few reports about its expression in gastric cancer. The aim of this study was to investigate its expression regulations in human gastric cancer and noncancerous mucosa, and the response to chemotherapeutic drugs in the gastric cancer cell line.MATERIALS AND METHODS: In one matched gastric cancer sample pair, the serial analysis of gene expression (SAGE) experiment was conducted to compare the gene expression profiles between cancerous and adjacent tissues. To detect the expression regulations among more cancerous tissues, microarrays were carried out and real-time RT-PCR was conducted to validate the results. At the protein level, Western blot and tissue microarray (TMA) examination were further used to verify S100A6 expression. The regulation. detection of S100A6 with flurouracil and doxorubicin at the mRNA and protein level was performed in the SGC7901 cell line.RESULTS: With the SAGE strategy, five times more S100A6 tags were identified in cancer tissues than in normal tissues. With the cDNA microarray, S100A6 was found to be significantly upregulated in 21 of 42 (50%) nonselective gastric cancers. In 10 other paired samples, the upregulation of S 100A6 was consolidated with RT-PCR and Western blot analysis as well. A total of 14 endoscopy-sectioned gastric noncancerous lesions and corresponding normal gastric mucosa were also applied to profile the gene expression; both cDNA microarray and RT-PCR demonstrated no significant alterations of S 100A6 at the mRNA level. TMA examination showed that 34 of 52 (65.4%) cancer samples were positively stained, while only 17 of 80 (21.3%) noncancerous lesions were positively detected and all nine normal mucosae were detected to be negative. An in vitro experiment showed that in the gastric cell line SGC-7901, S100A6 mRNA was detected to be upregulated from 24 to 72 h after treatment with 5 mg/L 5-flurouracil or 0.3 mg/L doxorubicin, and there were two wave upregulations of the S100A6 protein.CONCLUSION: The observed regulated expression of S100A6 suggests that it is associated with gastric cancer tumorigenesis and quantitation of S100A6 is a promising tool for diagnosis of gastric cancer.

The expression and biological significance of S100A6 protein in gastric carcinoma tissue

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

S100a6 Overexpression is Associated with Poor Prognosis and is Epigenetically Up-Regulated in Gastric Cancer

[Clinical Significance of S100A8 and S100A9 Expression in Gastric Cancer].

Upregulated Expression Of S100a6 In Human Gastric Cancer

Expression and clinical implication of S100A12 in gastric carcinoma

Clinical Significance of S100A6 Protein Expression in Human Lung Adenocarcinoma

Clinical Significance of S100A2 Expression in Gastric Cancer

[Regulation Mechanism Study of S100A6 on Invasion and Metastasis in Gastric Cancer].

Increased Expression of S100a6 Promotes Cell Proliferation in Gastric Cancer Cells

Presence of S100A9-positive Inflammatory Cells in Cancer Tissues Correlates with an Early Stage Cancer and a Better Prognosis in Patients with Gastric Cancer

Overexpression of S100A4 is Closely Associated with the Progression and Prognosis of Gastric Cancer in Young Patients.

Analysis of S100A6 protein expression and the clinical significance of patients with lung adenocarcinoma based on the method of immunohistochemisty

Expression of Novel Gene SNC66 in Gastric Cancer Tissue and Normal Gastric Mucosa

In Silico Analysis and Verification of S100 Gene Expression in Gastric Cancer

The Expression of Heat Shock Protein 70/90 in Patients with Atrophic Gastritis or Gastric Cancer and Its Significance

[Expression of Tissue Microarray P53, P16 and Cyclooxygenase-2 in Gastric Cancer].

Expression of 1A6 Gene and Its Correlation with Intestinal Gastric Carcinoma

Relationship Between S100A2 Expression and Promoter Methylation of Gastric Carcinoma

Expressions of S100A4 in lung cancer tissues and its clinical significance

Expression of Semaphorin 6D in Gastric Carcinoma and Its Significance.